NCT00003148View on ClinicalTrials.gov

Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

October 31, 1997

Primary Completion Date

April 30, 2001

Conditions
Leukemia
Interventions
BIOLOGICAL

aldesleukin

Trial Locations (10)

1000

Institut Jules Bordet, Brussels

41000

University Hospital Rebro, Zagreb

75181

Hotel Dieu de Paris, Paris

A-6020

Innsbruck Universitaetsklinik, Innsbruck

B-2650

Universitair Ziekenhuis Antwerpen, Edegem

F-94805

Institut Gustave Roussy, Villejuif

00144

Ospedale San Eugenio, Rome

00161

Azienda Policlinico Umberto Primo, Rome

2300 CA

Leiden University Medical Center, Leiden

NL-6252 HB

University Medical Center Nijmegen, Nijmegen

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK